000			02161 a2200613 4500
005			20250517110551.0
264		0	_c20170724
008			201707s 0 0 eng d
022			_a1590-3729
024	7		_a10.1016/j.numecd.2016.06.012 _2doi
040			_aNLM _beng _cNLM
100	1		_aBonfigli, A R
245	0	0	_aRandomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients. _h[electronic resource]
260			_bNutrition, metabolism, and cardiovascular diseases : NMCD _c10 2016
300			_a893-8 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial
650	0	4	_aAged
650	0	4	_aAmoxicillin _xadministration & dosage
650	0	4	_aAnti-Bacterial Agents _xadministration & dosage
650	0	4	_aBiomarkers _xblood
650	0	4	_aBlood Glucose _xmetabolism
650	0	4	_aClarithromycin _xadministration & dosage
650	0	4	_aDiabetes Mellitus, Type 2 _xblood
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEsomeprazole _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHelicobacter Infections _xblood
650	0	4	_aHelicobacter pylori _xdrug effects
650	0	4	_aHomeostasis
650	0	4	_aHost-Pathogen Interactions
650	0	4	_aHumans
650	0	4	_aInflammation Mediators _xblood
650	0	4	_aInsulin _xblood
650	0	4	_aInsulin Resistance
650	0	4	_aItaly
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aProton Pump Inhibitors _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aBoemi, M
700	1		_aFesta, R
700	1		_aBonazzi, P
700	1		_aBrandoni, G
700	1		_aSpazzafumo, L
700	1		_aOlivieri, F
700	1		_aCeriello, A
700	1		_aGenovese, S
700	1		_aTesta, R
773	0		_tNutrition, metabolism, and cardiovascular diseases : NMCD _gvol. 26 _gno. 10 _gp. 893-8
856	4	0	_uhttps://doi.org/10.1016/j.numecd.2016.06.012 _zAvailable from publisher's website
999			_c26286866 _d26286866